(Press-News.org) Neuropathic pain, caused by nerve or tissue damage, is the culprit behind many cases of chronic pain. It can be the result of an accident or caused by a variety of medical conditions and diseases such as tumors, lupus, and diabetes. Typically resistant to common types of pain management including ibuprofen and even morphine, neuropathic pain can lead to lifelong disability for many sufferers.
Now a drug developed by Tel Aviv University researchers, known as BL-7050, is offering new hope to patients with neuropathic pain. Developed by Prof. Bernard Attali and Dr. Asher Peretz of TAU's Department of Physiology and Pharmacology at the Sackler Faculty of Medicine, the medication inhibits the transmission of pain signals throughout the body. In both in-vitro and in-vivo experiments measuring electrical activity of neurons, the compound has been shown to prevent the hyper-excitability of neurons — protecting not only against neuropathic pain, but epileptic seizures as well.
The medication has been licensed by Ramot, TAU's technology transfer company, for development and commercialization by BioLineRx, an Israeli biopharmaceutical development company.
Targeting potassium for pain control
According to Prof. Attali, the medication works by targeting a group of proteins which act as a channel for potassium. Potassium has a crucial role in the excitability of cells, specifically those in the nervous system and the heart. When potassium channels don't function properly, cells are prone to hyper-excitability, leading to neurological and cardiovascular disorders such as epilepsy and arrhythmias. These are also the channels that convey pain signals caused by nerve or tissue damage, known as neuropathic pain.
With few treatment options available for neuropathic pain, Prof. Attali set out to develop a medication that could bind to and stabilize the body's potassium channels, controlling their hyper-excitability and preventing the occurrence of pain by keeping the channels open for the outflow of potassium. This novel targeting approach has been recently reported in the journal PNAS.
Inducing calm in the neurons
Understanding the mechanism that controls these channels has been crucial to the development of the drug. By successfully controlling the excitability of the neurons, Prof. Attali believes that BL-7050 could bring relief to hundreds of millions of patients around the world who suffer from neuropathic pain. The medication will reach the first phase of clinical trials in the near future.
In pre-clinical trials, BL-7050 was tested in rats experiencing both epilepsy and neuropathic pain and was found to be efficient in protecting against both when taken as a pill. While on the medication, rats were no longer affected by stimuli that had previously caused pain. Measures in the electrical activities of neurons also revealed that the medication was able to induce "calm" in the neurons, inhibiting pain pathways.
###
American Friends of Tel Aviv University (www.aftau.org) supports Israel's leading, most comprehensive and most sought-after center of higher learning. Independently ranked 94th among the world's top universities for the impact of its research, TAU's innovations and discoveries are cited more often by the global scientific community than all but 10 other universities.
Internationally recognized for the scope and groundbreaking nature of its research and scholarship, Tel Aviv University consistently produces work with profound implications for the future.
END
Durham, NC — Not all acts of altruism are alike, says a new study. From bees and wasps that die defending their nests, to elephants that cooperate to care for young, a new mathematical model pinpoints the environmental conditions that favor one form of altruism over another.
The model predicts that creatures will help each other in different ways depending on whether key resources such as food and habitat are scarce or abundant, say researchers from Indiana University and the National Evolutionary Synthesis Center in Durham, North Carolina.
Examples of creatures caring ...
PHILADELPHIA— To improve the quality of life in gay men and minorities treated for prostate cancer, a greater awareness of ethnic and sexual preference-related factors is needed to help men choose a more-suitable treatment plan, researchers from Thomas Jefferson University Hospital conclude in a literature review published May 1 in Nature Reviews Urology.
Some of the factors to consider, for example, include increased risk of urinary and bowel function decline in African Americans regardless of treatment received and differing sexual expectations and social support in ...
CAMBRIDGE, Mass. — Every year, U.S. supermarkets lose roughly 10 percent of their fruits and vegetables to spoilage, according to the Department of Agriculture. To help combat those losses, MIT chemistry professor Timothy Swager and his students have built a new sensor that could help grocers and food distributors better monitor their produce.
The new sensors, described in the journal Angewandte Chemie, can detect tiny amounts of ethylene, a gas that promotes ripening in plants. Swager envisions the inexpensive sensors attached to cardboard boxes of produce and scanned ...
Montreal, April 30, 2012 – What if there was a way to vastly improve the safety, durability and sustainability of bridges across North America without increasing spending? This was the question Saleh Abu Dabous set out to answer when he began his PhD at Concordia. "I was looking for an applied way to do research — something that would have an impact on society and improve the current situation," he remembers.
In a paper published in the Canadian Journal of Civil Engineering, Abu Dabous and his thesis supervisor Sabah Alkass, professor of in the Department of Building, ...
PHILADELPHIA – Two drugs commonly used to treat age-related macular degeneration (AMD) yield similar improvements in vision for patients receiving treatments on a monthly or as-needed basis, according to a study from researchers at the Center for Preventive Ophthalmology and Biostatistics (CPOB) at the Perelman School of Medicine at the University of Pennsylvania. The year-two results of the Comparison of AMD Treatment Trials (CATT) support the findings from the first year of the study that evaluated the effects of Avastin ® (bevacizumab) - the off-label drug most frequently ...
Hans Vogel, a professor in the biological sciences department, is the guest editor of a special issue of the journal Biochemistry and Cell Biology that focuses on lactoferrin, an important iron-binding protein with many health benefits.
"Some people describe this protein as the 'Swiss army knife' of the human host defense system," says Vogel. "We now know that lactoferrin has many functions in innate immunity and that it plays a role in protecting us from bacterial, viral, fungal, and protozoal infections. It can even protect us from some forms of cancer."
Lactoferrin—which ...
There was no change in concentrations of chloride, dissolved solids, or nitrate in groundwater for more than 50 percent of well networks sampled in a new analysis by the USGS that compared samples from 1988-2000 to samples from 2001-2010. For those networks that did have a change, seven times more networks saw increases as opposed to decreases.
The analysis was done by the USGS National Water Quality Assessment Program (NAWQA) to determine if concentrations of these constituents have increased or decreased significantly from the 1990's to the early 2000's nationwide. ...
It's very difficult to kick a star out of the galaxy.
In fact, the primary mechanism that astronomers have come up with that can give a star the two-million-plus mile-per-hour kick it takes requires a close encounter with the supermassive black hole at the galaxy's core.
So far astronomers have found 16 of these "hypervelocity" stars. Although they are traveling fast enough to eventually escape the galaxy's gravitational grasp, they have been discovered while they are still inside the galaxy.
Now, Vanderbilt astronomers report in the May issue of the Astronomical ...
Robert Stanek, bestselling author of over 150 published books, has a passion to help other independently published authors reach their goals. Stanek lives in Washington State, but his reach is international via the internet. Over the past 11 years he has developed several venues to help promote and market indie authors giving them more online exposure and visibility. He works diligently to offer ways in which to showcase new authors and books. One example is his blog readindies.blogspot.com (http://readindies.blogspot.com/).
Stanek started his writing career as a technical ...
ThePetCrib.com (http://www.thepetcrib.com/), a leading online store for upscale dog products and cat products announced today they will begin promotion one pet product a month as a special way to highlight their vendors products. The pet product of the month promotion will begin in May of 2012.
"We really work hard to represent vendors and pet products that are high quality and unique," said Bryan Cochran, owner of ThePetCrib.com. "The pet products we sell represent some of the best in the pet products industry. This is an opportunity for us to showcase ...
